📰 Query Get News
Page 58 - Query Get News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Query Get. Real-time updates on events, politics, business and more.
October 8, 2021
Amzell BV, a specialty pharmaceutical development company, announced it has a special protocol assessment agreement with the FDA for a phase 3 trial of its injectable infantile epileptic disease therapy. The treatment, AMZ002, is a sterile injectable hormone that would provide a purified synthetic polypeptide as an alternative to current FDA-approved epileptic seizure treatments. According to a
October 7, 2021
While the COVID-19 pandemic has put an incredible burden on all health care workers, it has also fueled a resurgence of anti-Asian racism in the U.S. and highlighted disparities in health care research and opportunities for Asian Americans. Patricia Mae G. Santos, MD, MS, a resident physician at the Memorial Sloan Kettering Cancer Center in New York, and colleagues argued in a recent
October 6, 2021
Clinical nudges, when geared towards increasing the salience of information, providing feedback and implementing default order sets in electronic systems, were “generally effective” in promoting adherence to guidelines, researchers wrote. However, the systematic review lacked data on the effectiveness of other types of nudges, including “anticipated error reduction, structuring
October 5, 2021
Results showed an overall higher level of psychological distress at baseline among patients undergoing surgery for cervical degenerative disease compared with historical controls of lumbar patients.In a subset analysis of a prospective, double-blind, randomized controlled trial, Shaleen Vira, MD, and colleagues screened 47 patients undergoing surgical treatment for primary cervical degenerative
October 5, 2021
The FDA issued an emergency use authorization for a rapid COVID-19 test that it said could dramatically increase at-home testing capacity in the United States. The authorization was issued for ACON Laboratories’ over-the-counter Flowflex COVID-19 antigen test for at-home use.
October 5, 2021
Patients who received enzyme-inducing antiseizure medications had increased risk for incident cardiovascular disease, according to results of a cohort study published in JAMA Neurology. “Regular use of [enzyme-inducing antiseizure medications (eiASMs)] can lead to dyslipidemia and hyperhomocysteinemia, which can lead to atherosclerosis,” Colin B. Josephson, MD, MSc, of Cumming School
October 4, 2021
Amid lockdowns, many countries implemented a suspension of routine surveillance for colorectal cancer, resulting in fewer diagnoses in older patients with more complications, according to a presentation during UEG Week Virtual. “We conclude that compared to the pre-pandemic period, the COVID pandemic was associated with a 40.4% decrease in the number of colorectal cancers diagnosed in a
October 2, 2021
The American Association for Cancer Research named Graham A. Colditz, MD, DrPH, MPH, the recipient of this year’s AACR Distinguished Lectureship on the Science of Cancer Health Disparities.Colditz will present his lecture Oct. 6 during the opening session of the virtual AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved. It
October 2, 2021
HIV self-testing kits were easy to use and widely accepted by people who inject drugs, who reported a desire to know their HIV status and to continuously be able to test, according to preliminary findings from a study presented at IDWeek. “People who inject drugs (PWID) are at significantly increased risk of acquiring HIV compared to the general population. Although health departments and
October 1, 2021
Surrogate insulin resistance measures positively predicted incident major depressive disorder among adults with no depression or anxiety disorder history, according to a study in American Journal of Psychiatry.“Several studies showed an association between insulin resistance and depression,” Kathleen T. Watson, PhD, of the department of psychiatry and behavioral sciences at Stanford